/PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,.
GALLIPOLIS – Holzer Health System on Wednesday announced a new formal affiliation between the Holzer Center for Cancer Care (HCCC) and Cleveland Clinic Cancer Center. This affiliation expands access to
A multi-center analysis of patients with invasive lobular carcinoma, or ILC -; the second most common histological subtype of invasive breast cancer in the U.S. -; showed that, despite its prevalence, ILC is detected later and has worse outcomes than the predominant subtype of invasive breast cancer, known as invasive ductal carcinoma (IDC), or no special type.